Odysight.ai Courts Wall Street to Fuel Defense AI Backlog Growth

NEW YORK, NY – November 09, 2026 – For micro-cap technology companies operating at the intersection of artificial intelligence and defense, the transition from research and development to commercial scaling is often perilous. It is a phase characterized by high cash burn, shifting revenue streams, and a desperate need for patient capital.

Odysight.ai Inc., a dual-listed provider of AI-powered visual sensing and predictive maintenance (PdM) solutions, is currently navigating this exact crucible. Today, the company announced that its executive leadership—Chief Executive Officer Yehu Ofer and Chief Financial Officer Einav Brenner—will embark on an aggressive institutional outreach campaign in New York City. The management team is scheduled to host in-person, one-on-one meetings at the 15th Annual ROTH Technology Conference on November 18, followed by the StoneX 15th Annual Discovery One-on-One Investor Conference on December 10.

Coordinated through MS-IR LLC, this back-to-back conference circuit is more than a routine investor relations exercise. It is a calculated capital markets maneuver. As the firm shifts its focus away from legacy commercial contracts toward high-stakes aerospace and defense deployments, management must convince Wall Street that its growing multi-million-dollar backlog will soon translate into recognized, sustainable revenue.

Trading Legacy Medical for Mission-Critical Defense

To understand the urgency behind Odysight.ai’s upcoming roadshow, one must look at the company’s recent financial restructuring. Over the past year, the firm made a deliberate strategic pivot, walking away from a lucrative but non-core Fortune 500 medical company contract. This move resulted in the full derecognition of a $1.69 million contract liability in early 2025, which severely impacted year-over-year top-line comparisons.

For the first half of 2026, the company reported revenues of just $0.5 million, a sharp decline from the $2.4 million recorded during the same period in 2025. Trailing twelve-month revenue currently sits at a modest $1.09 million.

However, a forensic look at the firm's pipeline reveals a compelling counter-narrative—one that Ofer and Brenner will undoubtedly be pitching to institutional portfolio managers in New York. While recognized revenue has temporarily plummeted, the company’s backlog has surged, reaching $16.45 million as of August 2026, up from $13.8 million at the end of 2025.

This backlog is built on a foundation of blue-chip aerospace and defense partnerships that most micro-cap firms take decades to secure. In August 2026, the firm received its first direct purchase order from Boeing to showcase its AI-powered predictive maintenance solution at two separate sites. Around the same time, Honeywell Aerospace commissioned a proof-of-concept collaboration to evaluate the technology across its Auxiliary Power Units (APU) portfolio.

"When you drop a legacy contract that was padding your top line, the market demands immediate replacement," noted one institutional equity analyst familiar with the Israeli tech sector. "They have replaced it with high-pedigree defense backlog, but now they have to prove they can convert those purchase orders into recognized revenue before the cash runway shortens."

The Hardware and AI Convergence

The technology driving these high-profile partnerships is highly specialized. Odysight.ai operates in the complex niche of condition-based monitoring (CBM) for harsh, hard-to-reach environments. By combining video-based micro-sensors with embedded software and real-time AI analytics, the company provides visibility into critical systems where continuous monitoring was previously impossible.

This capability has attracted significant attention from military organizations. The firm recently entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Air Warfare Center Aircraft Division (NAWCAD) to deploy AI-driven visual sensing on carrier arresting cables—a highly critical, high-stress application. Additionally, the Israeli Ministry of Defense, via Elbit Systems, issued a $0.3 million purchase order for immediate deployment, while the company’s predictive maintenance system is currently undergoing U.S. flight testing on a Sikorsky UH-60 Black Hawk Helicopter.

The pitch to Wall Street is straightforward: as global defense budgets swell and military branches seek to reduce equipment downtime through AI, Odysight.ai possesses field-tested, proprietary hardware-software integration that is already embedded with prime contractors.

The NASDAQ Uplisting and Institutional Appetite

Despite the impressive roster of clients, the company faces significant capital market headwinds, making the upcoming ROTH and StoneX conferences critical.

Incorporated in Nevada but headquartered in Ramat Gan, Israel, the firm is dual-listed on the Tel Aviv Stock Exchange (TASE) and NASDAQ. Since uplisting to the NASDAQ Capital Market in February 2025, the stock has struggled to maintain momentum. Currently trading around $1.75, the stock is down nearly 41% over the last 52 weeks.

The valuation dynamics are complex. With a market capitalization hovering around $44 million, the company is trading at a massive multiple relative to its trailing revenue, reflecting the market's pricing of its $16.45 million backlog. Furthermore, the stock suffers from liquidity constraints. A significant portion of the equity is tightly held by insiders, with Moshe Arkin beneficially owning over 33% of outstanding shares.

To bridge the gap between its current cash burn and future profitability, the company has had to tap the equity markets. In August 2026, the firm completed an $11 million public offering, selling shares at $3.20. With the stock currently trading well below that offering price, management faces the dual challenge of appeasing underwater investors while courting new institutional buyers.

Financially, the August raise provided a vital lifeline. The company reported a net loss of $9.5 million for the first half of 2026, with trailing twelve-month free cash flow at negative $16.07 million. However, with the estimated $9.9 million in net proceeds from the recent offering added to the $17.6 million in cash reported at the end of June, the firm has secured a robust runway. Crucially, the company carries no debt.

For the institutional investors sitting across the table from Ofer and Brenner in New York, the calculus will come down to execution risk. The company has successfully navigated the "red flags" of customer concentration by diversifying away from a single medical client and securing a foothold with Boeing, Honeywell, and the U.S. Navy. The technology has been validated by some of the most stringent engineering organizations on the planet.

The ultimate success story for Odysight.ai will depend on its ability to accelerate the deployment of its visual sensing platforms, moving from proof-of-concept testing to fleet-wide integration. If management can convince Wall Street that this inflection point is imminent, the current valuation may be viewed as a rare entry point into a pure-play defense AI asset.